Total Payments
$1,019
2019 Payments
$374.34
Companies
8
Transactions
54
Medicare Patients
2,246
Medicare Billing
$399,308
Payment Breakdown by Category
Food & Beverage$959.18 (94.1%)
Education$59.98 (5.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $959.18 | 52 | 94.1% |
| Education | $59.98 | 2 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $437.71 | 24 | $0 (2019) |
| Janssen Products, LP | $184.98 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $135.89 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $129.47 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $56.92 | 6 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $43.15 | 3 | $0 (2019) |
| Allergan Inc. | $18.11 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $12.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $374.34 | 16 | Janssen Products, LP ($154.99) |
| 2018 | $265.48 | 15 | ViiV Healthcare Company ($152.68) |
| 2017 | $379.34 | 23 | ViiV Healthcare Company ($161.43) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/23/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HIV | ||||||
| 08/21/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: HIV | ||||||
| 07/31/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/09/2019 | Janssen Products, LP | Symtuza (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.84 | General |
| 07/08/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/26/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: HIV | ||||||
| 05/29/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: HIV | ||||||
| 03/28/2019 | Janssen Products, LP | Symtuza (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/18/2019 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: HIV | ||||||
| 02/25/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.29 | General |
| 02/22/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2019 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: HIV | ||||||
| 01/23/2019 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: HIV | ||||||
| 12/19/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: Respiratory | ||||||
| 12/12/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.81 | General |
| 11/20/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 10/25/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: HIV | ||||||
| 09/12/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: HIV | ||||||
| 09/05/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.14 | General |
| 08/08/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: HIV | ||||||
| 06/20/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 522 | 1,007 | $130,480 | $87,687 |
| 2022 | 4 | 518 | 1,121 | $142,110 | $92,743 |
| 2021 | 4 | 461 | 1,027 | $128,560 | $85,448 |
| 2020 | 5 | 745 | 1,563 | $196,610 | $133,430 |
Total Patients
2,246
Total Services
4,718
Medicare Billing
$399,308
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 607 | $54,630 | $39,751 | 72.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 176 | 176 | $44,000 | $25,280 | 57.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 162 | 185 | $24,050 | $18,411 | 76.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 39 | $7,800 | $4,245 | 54.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 146 | 696 | $62,640 | $41,640 | 66.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 168 | 168 | $42,000 | $27,460 | 65.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 166 | 199 | $25,870 | $17,033 | 65.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 58 | $11,600 | $6,611 | 57.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 139 | 667 | $60,030 | $40,223 | 67.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 156 | 156 | $39,000 | $26,068 | 66.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 138 | 161 | $20,930 | $14,226 | 68.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 43 | $8,600 | $4,931 | 57.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 209 | 978 | $88,020 | $60,992 | 69.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 248 | 249 | $62,250 | $41,944 | 67.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 235 | 270 | $35,100 | $24,076 | 68.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 41 | 52 | $10,400 | $5,944 | 57.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 14 | $840.00 | $475.08 | 56.6% |
About Dr. Timothy Mess, M.D
Dr. Timothy Mess, M.D is a Infectious Disease healthcare provider based in Van Nuys, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043280076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Mess, M.D has received a total of $1,019 in payments from pharmaceutical and medical device companies, with $374.34 received in 2019. These payments were reported across 54 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($959.18).
As a Medicare-enrolled provider, Mess has provided services to 2,246 Medicare beneficiaries, totaling 4,718 services with total Medicare billing of $399,308. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Van Nuys, CA
- Active Since 01/23/2006
- Last Updated 01/29/2008
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043280076
Products in Payments
- TRIUMEQ (Drug) $229.10
- Symtuza (Drug) $177.61
- JULUCA (Drug) $133.07
- SIVEXTRO (Drug) $94.57
- DOVATO (Drug) $75.54
- PREZCOBIX (Drug) $64.29
- LONHALA MAGNAIR (Drug) $43.15
- ZERBAXA (Drug) $19.94
- AVYCAZ (Drug) $18.11
- CUBICIN RF (Drug) $14.96
- SUSTIVA (Drug) $12.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.